Literature DB >> 9097748

Preventative ophthalmology. Age-related macular degeneration.

N M Bressler1, S B Bressler.   

Abstract

PURPOSE: This report was designed to review the current knowledge about preventing the development or progression of age-related macular degeneration (AMD) and visual loss associated with this entity in practical terms for the comprehensive ophthalmologist.
METHODS: Animal studies, epidemiologic studies, and clinical trials identified through the use of MEDLINE, a reference list of articles reviewed, and personal contact with experts in this area provided information reviewed for this report.
RESULTS: Reports concerning ultraviolet and visible light provide limited, inconsistent, and conflicting data to support the theory that light exposure leads to AMD. Micronutrient supplementation is a provocative but largely unproven hypothesis. Positive associations of cigarette smoking and cardiovascular disease or certain risk factors for cardiovascular disease with AMD provide potential clues as to the underlying pathogenesis of AMD and are yet another reason to treat these health problems. Drusen may disappear after laser to the macula; however, this intervention will require careful, randomized, prospective trials to determine if this therapy can reduce the risk of choroidal neovascularization and visual loss developing in patients with AMD.
CONCLUSIONS: It is reasonable to have individuals wear sunglasses for comfort and possible protection from ultraviolet light exposure to all ocular structures (especially the lens) at little or no risk to the patient. Physicians probably should be reluctant to prescribe micronutrients or suggest other interventions (such as laser to drusen) until their health claims have been substantiated and their long-term safety soundly established.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9097748     DOI: 10.1016/s0161-6420(95)30889-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  20 in total

1.  Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3.

Authors: 
Journal:  Ophthalmology       Date:  2000-12       Impact factor: 12.079

2.  Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope.

Authors:  Henrike Wüstemeyer; Andreas Moessner; Cornelia Jahn; Sebastian Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-07-17       Impact factor: 3.117

Review 3.  [Pigment epithelial detachment in exudative macular degeneration: clinical characteristics and therapeutic options].

Authors:  A Lommatzsch
Journal:  Ophthalmologe       Date:  2010-12       Impact factor: 1.059

Review 4.  [Modern pharmacotherapy of age-related macular degeneration].

Authors:  F G Holz; H M Helb; A Bindewald-Wittich; H P N Scholl
Journal:  Internist (Berl)       Date:  2006-02       Impact factor: 0.743

Review 5.  Mechanisms for countering oxidative stress and damage in retinal pigment epithelium.

Authors:  Scott M Plafker; Gary B O'Mealey; Luke I Szweda
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

6.  VISUAL FUNCTION MEASURES IN EARLY AND INTERMEDIATE AGE-RELATED MACULAR DEGENERATION.

Authors:  Arthika Chandramohan; Sandra S Stinnett; John T Petrowski; Stefanie G Schuman; Cynthia A Toth; Scott W Cousins; Eleonora M Lad
Journal:  Retina       Date:  2016-05       Impact factor: 4.256

7.  Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy.

Authors:  U E Schnurrbusch; K Welt; L C Horn; P Wiedemann; S Wolf
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

8.  Prevalence and risks factors of age-related macular degeneration in Oklahoma Indians: the Vision Keepers Study.

Authors:  Amir L Butt; Elisa T Lee; Ronald Klein; Dana Russell; Gerald Ogola; Ann Warn; Ronald M Kingsley; Jeunliang Yeh
Journal:  Ophthalmology       Date:  2011-02-18       Impact factor: 12.079

9.  Role of cytosolic phospholipase A(2) in retinal neovascularization.

Authors:  Joshua M Barnett; Gary W McCollum; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

10.  [Transplantation of retinal pigment pithelium (RPE) following CNV removal in patients with AMD. Techniques, results, outlook].

Authors:  A Bindewald; F Roth; J Van Meurs; F G Holz
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.